• #1198059
  • AbbVie公司#00074230630

RINVOQ® Upadacitinib 15 mg Tablet Bottle 30 Tablets

RINVOQ ER, TAB 15MG (30/EA)

AbbVie公司00074230630
AbbVie公司00074230630
AbbVie公司00074230630
AbbVie公司00074230630
AbbVie公司00074230630
AbbVie公司00074230630
RINVOQ® Upadacitinib 15 mg Tablet Bottle 30 Tablets
RINVOQ® Upadacitinib 15 mg Tablet Bottle 30 Tablets
RINVOQ® Upadacitinib 15 mg Tablet Bottle 30 Tablets
RINVOQ® Upadacitinib 15 mg Tablet Bottle 30 Tablets
RINVOQ® Upadacitinib 15 mg Tablet Bottle 30 Tablets
RINVOQ® Upadacitinib 15 mg Tablet Bottle 30 Tablets
Compare
Features
  • RINVOQ® (upadacitinib) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers
  • Active psoriatic arthritis when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated
  • More …
Strength
15 mg 30 mg
Log In to Order
or
View Alternatives

Product Specifications

Features
  • RINVOQ® (upadacitinib) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers
  • Active psoriatic arthritis when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated

Professionals Also Viewed

No Image

  • #1205936
  • AbbVie公司#00074231030
RINVOQ® Upadacitinib 30 mg Tablet Bottle 30 Tablets
  • RINVOQ® (upadacitinib) a Janus kinase (JAK) inhibitor indicated for th …
  • RINVOQ is indicated for the treatment of adults with active psoriatic …
  • RINVOQ is indicated for the treatment of adults and pediatric patients …
Compare Products(0) Clear Compare